Status:
COMPLETED
Role of Recombinants in Peach Allergy
Lead Sponsor:
Niguarda Hospital
Conditions:
Food Allergy
Eligibility:
All Genders
18-80 years
Brief Summary
This study is aimed at verifying the role and the efficacy of the recombinants allergens Pru p 1, Pru p 3 and Pru p 4, Bet v 1, Bet v 2 and Bet v 4 in the diagnosis of peach allergy
Detailed Description
This study intend to verify whether the different levels of severity of the clinical allergic reactions to peach are associated to sensitization towards different allergenic molecules of peach. In par...
Eligibility Criteria
Inclusion
- female and male;
- pts with 18 e 80 years old;
- signature of the informed consent form;
- CAP/RAST positive for peach;
- clinical manifestation of peach allergy
Exclusion
- pregnancy;
- current antihistamine therapy;
- subjects that do not give consent to the study
Key Trial Info
Start Date :
July 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2010
Estimated Enrollment :
148 Patients enrolled
Trial Details
Trial ID
NCT00715156
Start Date
July 1 2008
End Date
November 1 2010
Last Update
February 22 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Niguarda Hospital
Milan, Italy, Italy, 20162